RxDoctor Payments Data

Carla Gunn

Obstetrics & Gynecology · Manchester, CTNPI 1447443494

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,460 of the $3,405 with a category attached, or 72.2%. Myovant Sciences Inc. accounts for 74.0% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2022 at $2,607 and has fallen 97.5% since, to $65 in 2025.

$3,405in general payments, 2019–2025

Across 52 payments — averaging $65.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Myovant Sciences Inc.$3K
  • AbbVie$139
  • Pfizer$111
  • Therapeuticsmd, Inc.$83
  • Exeltis, USA Inc.$73
  • BD$56
  • plus $425 from 18 others

What the payments were for

  • Speaking & faculty fees$2,46072%
  • Food & beverage$92927%
  • Education$160%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,405 in reported general payments places this provider in the 85th percentile of 605 obstetrics & gynecology providers in Connecticut.

See all obstetrics & gynecology providers in Connecticut →

Other obstetrics & gynecology in Manchester

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →